Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea · Delayed Price · Currency is KRW 9,210.00
-50.00 (-0.54%)
At close: Sep 15, 2025
KOSDAQ:318160 Revenue
Cell Bio Human Tech Co.,Ltd had revenue of 13.99B KRW in the quarter ending June 30, 2025, with 96.19% growth. This brings the company's revenue in the last twelve months to 37.61B, up 35.11% year-over-year. In the year 2024, Cell Bio Human Tech Co.,Ltd had annual revenue of 28.42B with 4.01% growth.
Revenue (ttm)
37.61B
Revenue Growth
+35.11%
P/S Ratio
1.98
Revenue / Employee
501.45M
Employees
75
Market Cap
74.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.42B | 1.09B | 4.01% |
| Dec 31, 2023 | 27.32B | -220.33M | -0.80% |
| Dec 31, 2022 | 27.54B | -7.62B | -21.66% |
| Dec 31, 2021 | 35.16B | 6.57B | 22.99% |
| Dec 31, 2020 | 28.59B | 4.49B | 18.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |